The present study shows, for the first time, that traditional treatment with MTF for an IR condition is able to re-establish the action of endogen insulin-sensitizing molecules, such as adiponectin, in endometrial tissue under pathological conditions, this being the effect of MTF independent of the PCOS condition. The gene discussed is ADIPOQ; the disease is polycystic ovary syndrome.